About Synchem
Synchem is a company based in Elk Grove Village (United States) founded in 1997 by Daniel Fang and Ze-Qi Xu was acquired by Formosa Laboratories in June 2024. Synchem offers products and services including Process Development, Bioconjugation, Peptide Synthesis, Small Molecule Synthesis, and Catalog Chemicals. Synchem operates in a competitive market with competitors including Sai Life Sciences, Acies Bio, Liverpool ChiroChem, NFIL and Personal Chemistry, among others.
- Headquarter Elk Grove Village, United States
- Founders Daniel Fang, Ze-Qi Xu
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Synchem, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Formosa Laboratories
(Jun 03, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Synchem
Synchem offers a comprehensive portfolio of products and services, including Process Development, Bioconjugation, Peptide Synthesis, Small Molecule Synthesis, and Catalog Chemicals.
Provides scalable solutions for chemical efficiency in pharmaceuticals.
Enables precision linking for advanced therapeutics development.
Tailors peptides for therapeutic and innovative applications.
Focuses on precision in complex molecular design and processes.
Offers ADC-related building blocks for research and development.
Funding Insights of Synchem
Detailed funding history for Synchem
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Synchem
Synchem has secured backing from 1 investor. Prominent investors backing the company include Formosa Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
APIs and pharmaceutical intermediates are manufactured by Formosa Laboratories.
|
Locked | Locked | Locked |
Investor details for Synchem
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synchem
Investment portfolio details for Synchem
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Synchem
Detailed financials for Synchem
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synchem Comparisons
Peer comparison for Synchem
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Synchem
Synchem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, Acies Bio, Liverpool ChiroChem, NFIL and Personal Chemistry, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
|
|
| Locked | Locked | Locked |
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
|
|
| Locked | Locked | Locked |
Small organic molecules are supplied for biotech and pharmaceutical R&D.
|
|
| Locked | Locked | Locked |
Fluorinated compounds are synthesized and manufactured customly for various industries.
|
|
| Locked | Locked | Locked |
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
|
|
| Locked | Locked | Locked |
Phenoxazine and dihydrophenazine are manufactured by New Iridium.
|
Detailed competitors of Synchem
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synchem
Complete news archive for Synchem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synchem
Synchem was founded in 1997.
Synchem is headquartered in Elk Grove Village, United States. It is registered at Elk Grove Village, Illinois, United States.
W Paul Mar is the current CEO of Synchem.
Synchem was established in 1997 in Elk Grove Village, United States, as a provider of custom organic synthesis, medicinal chemistry, and CMC services under cGMP conditions. Operations focus on supporting pharmaceutical and biotech clients through project completion, with over 4,500 initiatives delivered. The company is headquartered near Chicago and serves multinational firms in the life sciences sector.
Synchem's top competitors include Sai Life Sciences, Acies Bio and Liverpool ChiroChem.
Synchem offers Process Development, Bioconjugation, Peptide Synthesis, Small Molecule Synthesis, and Catalog Chemicals.
Synchem has 1 investor. Key investors include Formosa Laboratories.